BBS-BIOACTIVE BONE SUBSTITUTES PLC MANAGERS' TRANSACTIONS 21.02.2018 AT 20:30
BBS-Bioactive Bone Substitutes Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Jarmo Halonen
Position: Member of the Board/Deputy member
Issuer: BBS-Bioactive Bone Substitutes Oyj
LEI: 743700BYSBP0PCR6N767
Notification type: INITIAL NOTIFICATION
Reference number: 743700BYSBP0PCR6N767_20180221184849_3
____________________________________________
Transaction date: 2018-02-18
Venue: FIRST NORTH FINLAND (FNFI)
Instrument type: SHARE
ISIN: FI4000260583
Nature of the transaction: SUBSCRIPTION
Transaction details
(1): Volume: 10,800 Unit price: 5.5 EUR
Aggregated transactions
(1): Volume: 10,800 Volume weighted average price: 5.5 EUR
Further enquiries:
Pekka Jalovaara, CEO,
tel. +358 50 5529275, e-mail: pekka.jalovaara@bbs-artebone.fi
Hannu Säynäjäkangas, CFO,
tel. +358 40 5021092, e-mail: hannu.saynajakangas@bbs-artebone.fi
Hanna Tölli, Production Manager,
tel. +358 40 0953131, e-mail: hanna.tolli@bbs-artebone.fi
Certified Advisors:
First North Finland: Aalto Capital Partners Oy, tel. +358 40 5477 000
First North Sweden: Stockholm Certified Advisers AB, tel. +46 70 5516 729
BBS-Bioactive Bone Substitutes Plc ("BBS") is the health technology company operating since 2003. Before that there was a background of seven years of product development in the University of Oulu. We have developed a new product for healing of difficult bone fractures and for solving the problems in bone healing. Our mission is to offer new generation medicinal products for the orthopedic surgery. The research and development in the field of medicine requires perseverance and courage to develop new things. We have over 20 years of expertise in this. Our operations are characterised by top expertise, innovativeness and dedicated and committed employees. The ARTEBONE ®product is ready and the application process for the CE-mark has been initiated. BBS is the company having its headquarters in Oulu. We have our own production plant located in Reisjärvi and it is approved by FIMEA. More information: www.bbs-artebone.fi.
DISTRIBUTION
Nasdaq Helsinki Ltd
Nasdaq Stockholm Ltd